PARIS & PRINCETON, N.J.--(BUSINESS WIRE)--STENTYS (Paris:STNT) (FR0010949404 - STNT), a medical technology company commercializing the world’s first and only Self-Apposing® coronary stent, today announces its revenues and cash position at June 30, 2015.
Following a promising first quarter (with sales up 28%), STENTYS continues on its growth momentum with revenues increasing by 40% to €1.5 million in the second quarter of 2015.
Help employers find you! Check out all the jobs and post your resume.
